Suchergebnisse - "Misset, Benoit"

PubPharm (317)

41

Experimental Approach of Quadriceps Strength Measurement : Implications for Assessments in Critically Ill Survivors

enthalten in: Diagnostics (Basel, Switzerland) | 2022

von Rousseau, A. | Kellens, I. | Delanaye, P. | +3

42

Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19 : Preliminary Results of a Phase I/II Clinical Trial

enthalten in: Frontiers in immunology | 2022

von Grégoire, C. | Layios, N. | Lambermont, B. | +8

43

Automatized lung disease quantification in patients with COVID-19 as a predictive tool to assess hospitalization severity

enthalten in: Frontiers in medicine | 2022

von Guiot, J. | Maes, N. | Winandy, M. | +12

44

Clustering ICU patients with sepsis based on the patterns of their circulating biomarkers : A secondary analysis of the CAPTAIN prospective multicenter cohort study

enthalten in: PloS one | 2022

von Misset, B. | Philippart, F. | Fitting, C. | +10

45

Prevention of ventilator-associated pneumonia by noble metal coating of endotracheal tubes : a multi-center, randomized, double-blind study

enthalten in: Annals of intensive care | 2022

von Damas, P. | Legrain, C. | Lambermont, B. | +11

46

Prevention of ventilator-associated pneumonia by noble metal coating of endotracheal tubes: a multi-center, randomized, double-blind study

enthalten in: Annals of intensive care | 2022

von Damas, P. | Legrain, C. | Lambermont, B. | +11

47

Prevention of ventilator-associated pneumonia by noble metal coating of endotracheal tubes: a multi-center, randomized, double-blind study

enthalten in: Annals of intensive care | 2022

von Damas, P. | Legrain, C. | Lambermont, B. | +11

48

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Declercq, J. | Van Damme, K. | De Leeuw, E. | +40

CommentIn: Lancet Respir Med. 2021 Dec;9(12):1353-1354. - PMID 34756179

49

Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

enthalten in: The Journal of clinical investigation | 2021

von Nakanishi, T. | Pigazzini, S. | Degenhardt, F. | +146

UpdateOf: medRxiv. 2021 Mar 12;:. - PMID 33758887

50

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

enthalten in: BMC infectious diseases | 2021

von Axfors, C. | Janiaud, P. | Schmitt, A. | +205